IPHARMA is a contract research organization specialized in conducting clinical trials of investigational drugs in the Russian Federation and the EAEU.


IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center.


Download our company brochure

Results for 2020
IPHARMA entered the TOP-3 CROs by the number of CTAs in 2020







New projects

CTAs obtained



Clinical trials on COVID-19

Patients with COVID-19 enrolled

Original drugs registered

Original medical devices registered

Phase III-IV clinical trial of Gam-COVID-Vac in the Republic of Belarus

New service - package insert user testing

If you would like to report an adverse drug reaction, you can do this

by phone: +7 (495) 276-11-43

e-mail: sae@ipharma.ru

or by filling out the online form on the website.

IPHARMA is now collecting information on Normacor®.

Advantages of working with IPHARMA

1. Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2020.

2. Opportunities for drug localization, investments, and market access.

3. Full cycle of drug development: formulation, batches, QC, preclinical, clinical.

4. Medical and PV expertise with access to top scientists and KOLs.

5. Quality management systems and experienced staff.

IPHARMA contacts


5, Nobel street, Skolkovo Innovative Centre,  Moscow, 121205, Russia

Tel.: +7 (495) 276-11-43 
Fax: +7 (495) 276-11-47

E-mail: info@ipharma.ru

Personal data processing and storage policy